<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0037-8682</journal-id>
<journal-title><![CDATA[Revista da Sociedade Brasileira de Medicina Tropical]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Soc. Bras. Med. Trop.]]></abbrev-journal-title>
<issn>0037-8682</issn>
<publisher>
<publisher-name><![CDATA[Sociedade Brasileira de Medicina Tropical - SBMT]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0037-86822003000400013</article-id>
<article-id pub-id-type="doi">10.1590/S0037-86822003000400013</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Freqüência de soropositividade para antígenos de Toxocara canis em crianças de classes sociais diferentes]]></article-title>
<article-title xml:lang="en"><![CDATA[Frequency of seropositivity to Toxocara canis in children of different socioeconomic strata]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Campos Júnior]]></surname>
<given-names><![CDATA[Dioclécio]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Elefant]]></surname>
<given-names><![CDATA[Guita Rubinsky]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[Elisabeth Ourique de Melo e]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gandolfi]]></surname>
<given-names><![CDATA[Leonora]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jacob]]></surname>
<given-names><![CDATA[Cristina Miuki Abe]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tofeti]]></surname>
<given-names><![CDATA[Aline]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pratesi]]></surname>
<given-names><![CDATA[Riccardo]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Universidade de Brasília Faculdade de Medicina Departamento de Medicina da Criança e do Adolescente]]></institution>
<addr-line><![CDATA[Brasília DF]]></addr-line>
</aff>
<aff id="A02">
<institution><![CDATA[,Instituto de Medicina Tropical de São Paulo Laboratório de Imunologia e Biologia Molecular ]]></institution>
<addr-line><![CDATA[São Paulo SP]]></addr-line>
</aff>
<aff id="A03">
<institution><![CDATA[,Universidade de São Paulo Instituto da Criança Departamento de Pediatria]]></institution>
<addr-line><![CDATA[São Paulo SP]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>07</month>
<year>2003</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>07</month>
<year>2003</year>
</pub-date>
<volume>36</volume>
<numero>4</numero>
<fpage>509</fpage>
<lpage>513</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.br/scielo.php?script=sci_arttext&amp;pid=S0037-86822003000400013&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><self-uri xlink:href="http://www.scielo.br/scielo.php?script=sci_abstract&amp;pid=S0037-86822003000400013&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><self-uri xlink:href="http://www.scielo.br/scielo.php?script=sci_pdf&amp;pid=S0037-86822003000400013&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Para estudar a freqüência da infecção pelo Toxocara canis em crianças de classes sociais diferentes de Brasília, Brasil, foram testados soros de 602 crianças de ambos os sexos, de 1 a 12 anos, distribuídas em dois grupos representativos de condições socioeconômicas distintas. As amostras do primeiro grupo foram obtidas em laboratório público que atende bairros pobres. As do segundo grupo foram colhidas em laboratório privado, que serve à classe média. Os anticorpos anti-Toxocara foram detectados pelo método ELISA, com antígenos de Toxocara canis, e absorção com antígenos do Ascaris suum. A prevalência de soropositividade foi de 21,8% (66/302) no primeiro grupo e de 3% (9/300) no segundo (p<0,0001). Não houve diferença quanto ao gênero ou idade das crianças. Os resultados sugerem significativa prevalência de toxocaríase na população infantil de Brasília, com predomínio nas classes sociais menos favorecidas economicamente.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Frequency of seropositivity for Toxocara in children from different socioeconomic strata in the city of Brasilia (Brazil) was measured. Six hundred and two children of both sexes, aged one to 12 years were distributed in two socioeconomically distinct groups. The samples of sera of the first group were obtained from blood drawn for routine tests in the laboratory of a public hospital attending children from low-income families. Samples from the second group were obtained from private laboratories attending children from middle-class families. Anti-toxocara antibodies were detected by ELISA, using Toxocara canis excretory-secretory antigens previously absorbed with Ascaris suum extract. The prevalence of seropositivity was 21.8% (66/302) in the first group and 3% (9/300) in the second (p< 0.0001). No differences in frequency according to age or sex could be detected. Our results suggest a high prevalence of childhood toxocariasis in Brasilia, with children from lower income brackets being the most affected.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Toxocaríase]]></kwd>
<kwd lng="pt"><![CDATA[Larva migrans visceral]]></kwd>
<kwd lng="pt"><![CDATA[Toxocara canis]]></kwd>
<kwd lng="pt"><![CDATA[ELISA]]></kwd>
<kwd lng="en"><![CDATA[Toxocariasis]]></kwd>
<kwd lng="en"><![CDATA[Visceral larva migrans]]></kwd>
<kwd lng="en"><![CDATA[Toxocara canis]]></kwd>
<kwd lng="en"><![CDATA[ELISA]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">ARTIGO    </font></b></p>     <p>&nbsp;</p>     <p><b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="4"><a name="top"></a>Freq&uuml;&ecirc;ncia    de soropositividade para ant&iacute;genos de <i>Toxocara canis</i> em crian&ccedil;as    de classes sociais diferentes</font></b></p>     <p>&nbsp;</p>     <p><b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="3">Frequency    of seropositivity to <i>Toxocara canis</i> in children of different socioeconomic    strata</font></b></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Diocl&eacute;cio    Campos J&uacute;nior<sup>I</sup>; Guita Rubinsky Elefant<sup>II</sup>; Elisabeth    Ourique de Melo e Silva<sup>II</sup>; Leonora Gandolfi<sup>I</sup>; Cristina    Miuki Abe Jacob<sup>III</sup>; Aline Tofeti<sup>I</sup>; Riccardo Pratesi<sup>I</sup></font></b></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><sup>I</sup>Departamento    de Medicina da Crian&ccedil;a e do Adolescente da Faculdade de Medicina da Universidade    de Bras&iacute;lia, Bras&iacute;lia, DF    <br>   </font><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><sup>II</sup>Laborat&oacute;rio    de Imunologia e Biologia Molecular do Instituto de Medicina Tropical de S&atilde;o    Paulo, S&atilde;o Paulo, SP    ]]></body>
<body><![CDATA[<br>   </font><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><sup>III</sup>Departamento    de Pediatria do Instituto da Crian&ccedil;a da Universidade de S&atilde;o Paulo,    S&atilde;o Paulo, SP</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><a href="#back10">Endere&ccedil;o    para correspond&ecirc;ncia</a></font></p>     <p>&nbsp;</p>     <p>&nbsp;</p> <hr size="1" noshade>     <p><b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">RESUMO</font></b></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Para estudar    a freq&uuml;&ecirc;ncia da infec&ccedil;&atilde;o pelo <i>Toxocara canis</i>    em crian&ccedil;as de classes sociais diferentes de Bras&iacute;lia, Brasil,    foram testados soros de 602 crian&ccedil;as de ambos os sexos, de 1 a 12 anos,    distribu&iacute;das em dois grupos representativos de condi&ccedil;&otilde;es    socioecon&ocirc;micas distintas. As amostras do primeiro grupo foram obtidas    em laborat&oacute;rio p&uacute;blico que atende bairros pobres. As do segundo    grupo foram colhidas em laborat&oacute;rio privado, que serve &agrave; classe    m&eacute;dia. Os anticorpos anti-<i>Toxocara</i> foram detectados pelo m&eacute;todo    ELISA, com ant&iacute;genos de <i>Toxocara canis</i>, e absor&ccedil;&atilde;o    com ant&iacute;genos do <i>Ascaris suum</i>. A preval&ecirc;ncia de soropositividade    foi de 21,8% (66/302) no primeiro grupo e de 3% (9/300) no segundo (p&lt;0,0001).    N&atilde;o houve diferen&ccedil;a quanto ao g&ecirc;nero ou idade das crian&ccedil;as.    Os resultados sugerem significativa preval&ecirc;ncia de toxocar&iacute;ase    na popula&ccedil;&atilde;o infantil de Bras&iacute;lia, com predom&iacute;nio    nas classes sociais menos favorecidas economicamente.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><b>Palavras-chaves:</b>    Toxocar&iacute;ase. Larva migrans visceral.<i> Toxocara canis</i>. ELISA.</font></p> <hr size="1" noshade>     <p><b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">ABSTRACT</font></b></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Frequency    of seropositivity for <i>Toxocara</i> in children from different socioeconomic    strata in the city of Brasilia (Brazil) was measured. Six hundred and two children    of both sexes, aged one to 12 years were distributed in two socioeconomically    distinct groups. The samples of sera of the first group were obtained from blood    drawn for routine tests in the laboratory of a public hospital attending children    from low-income families. Samples from the second group were obtained from private    laboratories attending children from middle-class families. Anti-<i>toxocara</i>    antibodies were detected by ELISA, using <i>Toxocara canis</i> excretory-secretory    antigens previously absorbed with <i>Ascaris suum</i> extract. The prevalence    of seropositivity was 21.8% (66/302) in the first group and 3% (9/300) in the    second (p&lt; 0.0001). No differences in frequency according to age or sex could    be detected. Our results suggest a high prevalence of childhood toxocariasis    in Brasilia, with children from lower income brackets being the most affected.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><b>Keywords:</b>    Toxocariasis. Visceral larva migrans.<i> Toxocara canis</i>. ELISA</font></p> <hr size="1" noshade>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">A toxocar&iacute;ase    &eacute; uma zoonose muito difundida em todo o mundo<sup>17</sup>. Trata-se    da infec&ccedil;&atilde;o do hospedeiro humano pelas larvas de <i>Toxocara canis</i>    ou de <i>Toxocara cati</i>, nemat&oacute;ides que parasitam c&atilde;es ou gatos.    Descrita por Beaver et al<sup>4</sup>, em 1952, a toxocar&iacute;ase &eacute;    tamb&eacute;m conhecida por s&iacute;ndrome da larva migrans visceral.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">O parasitismo    humano &eacute; conseq&uuml;&ecirc;ncia da ingest&atilde;o acidental de ovos    embrionados de <i>Toxocara</i>, eliminados no solo juntamente com as fezes dos    seus hospedeiros naturais. A larva liberada no intestino delgado penetra a parede    intestinal migrando para as v&iacute;sceras em geral, onde exerce suas a&ccedil;&otilde;es    patog&ecirc;nicas. Entre os m&uacute;ltiplos quadros cl&iacute;nicos que produz,    incluindo os casos assintom&aacute;ticos, salientam-se manifesta&ccedil;&otilde;es    al&eacute;rgicas, hipereosinofilia, fraqueza cr&ocirc;nica, dor abdominal, al&eacute;m    da forma visceral cl&aacute;ssica da doen&ccedil;a, marcada pelo comprometimento    hep&aacute;tico e pulmonar, bem como da localiza&ccedil;&atilde;o ocular, considerada    uma das causas mais freq&uuml;entes de cegueira na crian&ccedil;a<sup>18</sup>.    Representa um problema de sa&uacute;de p&uacute;blica de grande relev&acirc;ncia    que n&atilde;o tem merecido os estudos e a interven&ccedil;&atilde;o necess&aacute;ria    para a redu&ccedil;&atilde;o do seu impacto populacional.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">O diagn&oacute;stico    da toxocar&iacute;ase humana baseia-se essencialmente em testes imunol&oacute;gicos    por ser muito dif&iacute;cil<sup>16</sup> a demonstra&ccedil;&atilde;o das larvas    de <i>Toxocara sp</i> em material de bi&oacute;psia. Os estudos da freq&uuml;&ecirc;ncia    de soropositividade para ant&iacute;genos de <i>Toxocara sp</i> possibilitam    a delimita&ccedil;&atilde;o da import&acirc;ncia desta zoonose em determinada    regi&atilde;o, prestando-se como instrumento valioso para fundamentar a ado&ccedil;&atilde;o    de medidas educativas e preventivas.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">A maioria    dos estudos feitos em diversas regi&otilde;es do mundo n&atilde;o leva em considera&ccedil;&atilde;o    poss&iacute;veis diferen&ccedil;as decorrentes das desigualdades sociais que    diferenciam segmentos populacionais de um mesmo territ&oacute;rio. Dadas as    caracter&iacute;sticas do ciclo de transmiss&atilde;o da toxocar&iacute;ase,    &eacute; poss&iacute;vel que as crian&ccedil;as pertencentes &agrave;s classes    pobres, vivendo em condi&ccedil;&otilde;es higi&ecirc;nicas desfavor&aacute;veis,    mais expostas ao contacto com o solo contaminado, sejam mais suscet&iacute;veis    &agrave;s conseq&uuml;&ecirc;ncias deste parasitismo.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">O presente    trabalho teve por objetivo comparar a freq&uuml;&ecirc;ncia de soro-positividade    contra ant&iacute;genos de <i>Toxocara canis</i> em crian&ccedil;as que habitam    a periferia pobre de Bras&iacute;lia com a das crian&ccedil;as que vivem nos    condom&iacute;nios e quadras residenciais de classe m&eacute;dia da cidade.    O projeto foi aprovado pelo Comit&ecirc; de &Eacute;tica de Pesquisa em Humanos    da Faculdade de Medicina da Universidade de Bras&iacute;lia.</font></p>     <p>&nbsp;</p>     <p><b><font face="Verdana, Arial, Helvetica, sans-serif" size="3">PACIENTES E    M&Eacute;TODOS</font></b></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">O modelo    escolhido foi o do estudo transversal para a an&aacute;lise de freq&uuml;&ecirc;ncia    da soropositividade ao ant&iacute;geno de <i>T. canis</i>.</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">A amostra    consistiu de dois grupos de crian&ccedil;as. O primeiro, denominado Grupo A,    foi constitu&iacute;do por 302 crian&ccedil;as atendidas no ambulat&oacute;rio    do Hospital Universit&aacute;rio de Bras&iacute;lia. Re&uacute;ne crian&ccedil;as    representativas da popula&ccedil;&atilde;o de baixo n&iacute;vel socioecon&ocirc;mico,    usu&aacute;ria do sistema p&uacute;blico de sa&uacute;de. O segundo grupo, denominado    Grupo B, foi composto por 300 crian&ccedil;as atendidas em cl&iacute;nicas e    laborat&oacute;rios particulares ou de planos de sa&uacute;de, caracterizando-se,    conseq&uuml;entemente, como uma amostra populacional de n&iacute;vel socioecon&ocirc;mico    elevado. Em cada grupo foram inclu&iacute;das crian&ccedil;as de 1 a 12 anos    de idade, de ambos os sexos, submetidas a coleta de sangue para a realiza&ccedil;&atilde;o    de diferentes exames laboratoriais, solicitados para esclarecimento de sinais    e sintomas diversos, sem presun&ccedil;&atilde;o diagn&oacute;stica de toxocar&iacute;ase.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">A determina&ccedil;&atilde;o    da presen&ccedil;a de anticorpos anti-<i>T. canis</i> foi feita segundo a t&eacute;cnica    de ELISA descrita a seguir.</font></p>     <p><b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Ant&iacute;genos.</font></b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">    Para o teste imunoenzim&aacute;tico ELISA (Enzyme Linked Immunosorbent Assay)    foi utilizado ant&iacute;geno de Excre&ccedil;&atilde;o e Secre&ccedil;&atilde;o    (TES) de larvas de <i>Toxocara canis</i> obtido segundo De Savigny<sup>6 7</sup>,    com algumas modifica&ccedil;&otilde;es<sup>9</sup>. As larvas foram liberadas    dos ovos e cultivadas em meio de Eagle, isento de soro. O ant&iacute;geno foi    acrescido de inibidor de protease (Phenyl-methyl-sulphonyl-fluoride) 200mM (5&#181;l/ml    de meio coletado), dialisado em &aacute;gua destilada, centrifugado a 4&deg;C,    a 15.000rpm, por 60min, e filtrado em membrana Millipore de 0,22&#181;. Foi    feita a dosagem prot&eacute;ica pelo m&eacute;todo de Lowry<sup>12</sup>(630&#181;/ml)    e o ant&iacute;geno foi conservado em al&iacute;quotas a -20&deg;.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Para a absor&ccedil;&atilde;o    dos soros, foi utilizado extrato antig&ecirc;nico de vermes de <i>Ascaris suum</i>,    obtidos do intestino de su&iacute;nos, segundo Kanamura et al<sup>11</sup>,    com modifica&ccedil;&otilde;es. Os vermes foram macerados em graal em &aacute;gua    destilada, acrescidos de NaOH (1M) numa propor&ccedil;&atilde;o de 1,5ml/ 8,5ml    de extrato. Neutralizou-se a solu&ccedil;&atilde;o com HCl 6M e centrifugou-se    a 2.000rpm, por 10 minutos. Foi feita a dosagem prot&eacute;ica pelo m&eacute;todo    de Lowry<sup>12</sup> (5mg/ml), a seguir a solu&ccedil;&atilde;o foi filtrada    em papel Whatman, e foi acrescida de 1/3 do seu volume de &eacute;ter para que    fosse efetuada a deslipida&ccedil;&atilde;o. A camada et&eacute;rea foi removida.    O extrato antig&ecirc;nico foi filtrado em membrana de Millipore de 0,22&#181;m    e conservado em al&iacute;quotas a -20&deg;C.</font></p>     <p><b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Ensaio    sorol&oacute;gico.</font></b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">    Teste Imunoenzim&aacute;tico ELISA-IgG, baseado no m&eacute;todo descrito por    de Savigny<sup>8</sup>, com modifica&ccedil;&otilde;es<sup>9</sup>. Placas de    poliestireno com fundo em <i>U</i> foram sensibilizadas com 0,130&#181;g de    ant&iacute;geno TES em solu&ccedil;&atilde;o tamp&atilde;o carbonato-bicarbonato    0,1M, pH 9,6. Para o bloqueio foi utilizada solu&ccedil;&atilde;o de soro albumina    bovina a 1% em solu&ccedil;&atilde;o salina tamponada com fosfatos, contendo    Tween-20 a 0,05% (PBS-T). Os soros foram absorvidos a 1/160 em solu&ccedil;&atilde;o    de <i>Ascaris suum</i> a 1/200 em PBS-T, por 30 minutos a 37&deg;C e a seguir    foi feita a dilui&ccedil;&atilde;o para 1/320 em PBS-T, e testados em duplicata.    O conjugado (anti-IgG humano marcado com peroxidase- Biolab) foi dilu&iacute;do    a 1/4000 em PBS-T. Como solu&ccedil;&atilde;o crom&oacute;gena, utilizou-se    solu&ccedil;&atilde;o de ortofenilenodiamina a 0,01%, em tamp&atilde;o acetato    0,05M, pH 4,5 acrescido de per&oacute;xido de hidrog&ecirc;nio 30% na concentra&ccedil;&atilde;o    final de 0,05%. Ap&oacute;s 20 minutos &agrave; temperatura ambiente e isento    de luz, a rea&ccedil;&atilde;o foi bloqueada pela adi&ccedil;&atilde;o de &aacute;cido    sulf&uacute;rico 2N. A densidade &oacute;ptica (DO) foi obtida a 492nm, em aparelho    Titertek Multiscan MMC/340. Em todos os testes foram inclu&iacute;dos soros    padr&atilde;o reagente e n&atilde;o reagente e um soro limiar de reatividade    (SLR). Amostras com DOs acima dos valores das DOs do SLR foram consideradas    reagentes.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Utilizou-se    o programa Epi-info, vers&atilde;o 6, para os tratamentos estat&iacute;sticos    que consistiram no c&aacute;lculo do qui-quadrado para compara&ccedil;&atilde;o    de preval&ecirc;ncias, admitindo-se como limite de signific&acirc;ncia o valor    de p inferior a 0,05.</font></p>     <p>&nbsp;</p>     <p><b><font face="Verdana, Arial, Helvetica, sans-serif" size="3">RESULTADOS</font></b></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">As caracter&iacute;sticas    das crian&ccedil;as nos dois grupos est&atilde;o apresentadas na <a href="#tabela1">Tabela    1</a>, na qual se verifica composi&ccedil;&atilde;o homog&ecirc;nea quanto ao    g&ecirc;nero e as idades das crian&ccedil;as cujos soros foram testados.</font></p>     <p align="center"><a name="tabela1"></a></p>     ]]></body>
<body><![CDATA[<p align="center">&nbsp;</p>     <p align="center"><img src="/img/revistas/rsbmt/v36n4/16731t1.gif"></p>     <p align="center">&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">A <a href="#tabela2">Tabela    2</a> re&uacute;ne os resultados dos testes realizados nos dois grupos de crian&ccedil;as    e a signific&acirc;ncia estat&iacute;stica das diferen&ccedil;as evidenciadas.    Foram testadas 602 amostras de soros. Dos 302 soros testados no grupo A, constitu&iacute;do    por crian&ccedil;as de baixo n&iacute;vel s&oacute;cio econ&ocirc;mico, 66(21,8%)    foram positivos, enquanto que dos soros extra&iacute;dos do sangue de crian&ccedil;as    do grupo B, pertencentes a estrato de n&iacute;vel socioecon&ocirc;mico diferenciado,    apenas 9(3%) resultaram positivos.</font></p>     <p align="center"><a name="tabela2"></a></p>     <p align="center">&nbsp;</p>     <p align="center"><img src="/img/revistas/rsbmt/v36n4/16731t2.gif"></p>     <p align="center">&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">A distribui&ccedil;&atilde;o    da soropositividade em fun&ccedil;&atilde;o do g&ecirc;nero &eacute; mostrada    na <a href="#tabela3">Tabela 3</a>. N&atilde;o houve diferen&ccedil;a de preval&ecirc;ncia    em fun&ccedil;&atilde;o das idades das crian&ccedil;as que foram objeto dos    testes realizados.</font></p>     <p align="center"><a name="tabela3"></a></p>     ]]></body>
<body><![CDATA[<p align="center">&nbsp;</p>     <p align="center"><img src="/img/revistas/rsbmt/v36n4/16731t3.gif"></p>     <p>&nbsp;</p>     <p><b><font face="Verdana, Arial, Helvetica, sans-serif" size="3">DISCUSS&Atilde;O</font></b></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">A preocupa&ccedil;&atilde;o    com a preval&ecirc;ncia de toxocar&iacute;ase na popula&ccedil;&atilde;o infantil    tem justificado a realiza&ccedil;&atilde;o de inqu&eacute;ritos sorol&oacute;gicos    em v&aacute;rios pa&iacute;ses. Os resultados apontam, na maioria dos estudos    efetuados, evid&ecirc;ncias significativas da preval&ecirc;ncia desta zoonose,    independentemente do n&iacute;vel socioecon&ocirc;mico das popula&ccedil;&otilde;es    estudadas. Ademais, a associa&ccedil;&atilde;o entre toxocar&iacute;ase e a    presen&ccedil;a de sintomas cl&iacute;nicos diversos e potencialmente graves    na crian&ccedil;a refor&ccedil;a a import&acirc;ncia de se considerar esta doen&ccedil;a    como um importante problema de sa&uacute;de p&uacute;blica<sup>19</sup>.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">A preval&ecirc;ncia    de toxocar&iacute;ase na cidade de Bras&iacute;lia n&atilde;o &eacute; conhecida.    No entanto, como a cria&ccedil;&atilde;o de c&atilde;es dom&eacute;sticos tornou-se    pr&aacute;tica crescente em todos os setores da cidade, tanto naqueles habitados    por popula&ccedil;&atilde;o economicamente bem situada quanto naqueles em que    vivem os contingentes mais pobres dos seus moradores, &eacute; de se supor que    a toxocar&iacute;ase seja tamb&eacute;m uma nosologia prevalente nesta cidade.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">O crit&eacute;rio    empregado para a separa&ccedil;&atilde;o dos dois grupos populacionais selecionados    foi simples e objetivo tendo em vista que o sistema p&uacute;blico de sa&uacute;de    &eacute; utilizado quase que exclusivamente pelas popula&ccedil;&otilde;es pobres    do pa&iacute;s, enquanto as institui&ccedil;&otilde;es privadas atendem unicamente    a demanda dos segmentos populacionais de classe m&eacute;dia. Assim, os dois    grupos estudados s&atilde;o representativos das condi&ccedil;&otilde;es de vida    de seus integrantes e se prestam bem &agrave; compara&ccedil;&atilde;o de freq&uuml;&ecirc;ncias    dado que s&atilde;o homog&ecirc;neos no tocante &agrave;s demais vari&aacute;veis    analisadas, como se observa na <a href="#tabela1">Tabela 1</a>. No primeiro    deles, est&atilde;o as crian&ccedil;as que, em geral, vivem em locais desprovidos    de infra-estrutura sanit&aacute;ria, residindo em casas de constru&ccedil;&atilde;o    prec&aacute;ria, sem condi&ccedil;&otilde;es adequadas de higiene, convivendo    com grande n&uacute;mero de c&atilde;es que eliminam suas fezes sobre o solo,    na proximidade das casas. No segundo grupo est&atilde;o inclu&iacute;das as    crian&ccedil;as que residem geralmente em apartamentos dotados de condi&ccedil;&otilde;es    ideais de saneamento, localizados em &aacute;reas privilegiadas do espa&ccedil;o    urbano de Bras&iacute;lia. Embora convivam tamb&eacute;m com n&uacute;mero significativo    de c&atilde;es, a possibilidade de ingest&atilde;o de ovos embrionados de <i>T.    canis</i> &eacute; certamente menor neste grupo, seja por conta de h&aacute;bitos    higi&ecirc;nicos mais desenvolvidos, seja pelo tratamento regular dos c&atilde;es    com medicamentos antiparasit&aacute;rios. &Eacute; poss&iacute;vel, ainda, que    o melhor estado de nutri&ccedil;&atilde;o destas crian&ccedil;as represente,    tamb&eacute;m, um fator de prote&ccedil;&atilde;o contra a penetra&ccedil;&atilde;o    intestinal das larvas.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Os resultados    obtidos nos testes sorol&oacute;gicos realizados neste trabalho revelam diferen&ccedil;a    significativa entre a freq&uuml;&ecirc;ncia de soropositividade ao <i>T. canis</i>    observada em crian&ccedil;as procedentes dos bairros pobres de Bras&iacute;lia    e a que se constata nas crian&ccedil;as residentes nos setores mais ricos da    cidade, conforme se observa na <a href="#tabela2">Tabela 2</a>. A possibilidade    de rea&ccedil;&atilde;o cruzada com ant&iacute;genos de outros parasitas causa    de erros diagn&oacute;sticos conhecida , foi descartada, no presente estudo,    pela absor&ccedil;&atilde;o preliminar das amostras sorol&oacute;gicas com ant&iacute;genos    do <i>A. suum,</i> nemat&oacute;ide relacionado antigenicamente com o <i>Ascaris    lumbricoides</i>, que &eacute; um parasita intestinal comum em crian&ccedil;as,    e cuja infesta&ccedil;&atilde;o poderia falsear o teste de ELISA para identifica&ccedil;&atilde;o    de anticorpos contra o <i>T. canis</i><sup>15</sup>.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Embora a    amostra populacional estudada n&atilde;o permita definir a preval&ecirc;ncia    da toxocar&iacute;ase para a popula&ccedil;&atilde;o de Bras&iacute;lia, os    resultados apontam para prov&aacute;vel relev&acirc;ncia desta zoonose no Distrito    Federal. De fato, a freq&uuml;&ecirc;ncia de 21,8% encontrada nas crian&ccedil;as    da periferia de Bras&iacute;lia compara-se com a de 37,9% em regi&atilde;o subtropical    da Argentina<sup>2</sup>; 39% na cidade de la Plata<sup>17</sup>; de 29,6% na    Nig&eacute;ria<sup>1</sup>; 22% na regi&atilde;o oeste da Fran&ccedil;a<sup>10</sup>;    30% na periferia de Caracas<sup>13</sup>; 27,2% na popula&ccedil;&atilde;o escolar    de Trinidad<sup>3</sup>. Na maior parte desses estudos, os testes sorol&oacute;gicos    foram feitos em crian&ccedil;as previamente triadas pelo crit&eacute;rio da    hipereosinofilia ou da presen&ccedil;a de sinais cl&iacute;nicos sugestivos    de toxocar&iacute;ase, diferentemente do presente estudo, que n&atilde;o utilizou    qualquer um desses crit&eacute;rios.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Os resultados    obtidos mostram, com elevada signific&acirc;ncia, o impacto das desigualdades    sociais como fator determinante da alta preval&ecirc;ncia desta doen&ccedil;a    parasit&aacute;ria nas popula&ccedil;&otilde;es mais pobres. Neste sentido,    os dados encontrados est&atilde;o de acordo com Cilla e cols<sup>5</sup>, que    referem preval&ecirc;ncia de soropositividade para <i>T. canis</i> de 0% em    crian&ccedil;as de classe m&eacute;dia e de 37% em crian&ccedil;as pobres de    uma regi&atilde;o do pa&iacute;s Basco. No estudo realizado por Silva FM e cols<sup>18</sup>    em 100 crian&ccedil;as escolhidas aleatoriamente entre a popula&ccedil;&atilde;o    infantil internada em hospital da cidade de Vit&oacute;ria, estado do Esp&iacute;rito    Santo, no Brasil, a preval&ecirc;ncia foi de 39%. Estes autores n&atilde;o observaram    diferen&ccedil;a na soropositividade para <i>T. canis</i> entre crian&ccedil;as    oriundas de classes sociais distintas porque a amostra estudada foi pequena    e, al&eacute;m disto, o hospital atende unicamente pacientes do sistema p&uacute;blico    de sa&uacute;de, n&atilde;o permitindo a caracteriza&ccedil;&atilde;o de dois    grupos populacionais de n&iacute;veis socioecon&ocirc;micos distintos, como    foi feito no presente trabalho. Nos dois grupos por n&oacute;s estudados, a    freq&uuml;&ecirc;ncia de soropositividade para <i>Toxocara canis</i> n&atilde;o    apresentou diferen&ccedil;a significativa quanto &agrave;s faixas et&aacute;rias,    nem quanto ao sexo das crian&ccedil;as, como mostra a <a href="#tabela3">Tabela    3</a>. Esta observa&ccedil;&atilde;o confirma conclus&otilde;es de estudo semelhante    realizado no Brasil<sup>18</sup>.</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Considerando    que os resultados encontrados sugerem forte ind&iacute;cio de que a toxocar&iacute;ase    seja um problema importante de sa&uacute;de para a popula&ccedil;&atilde;o do    Distrito Federal, torna-se necess&aacute;ria a realiza&ccedil;&atilde;o de um    inqu&eacute;rito sorol&oacute;gico populacional que permita dimensionar, com    o rigor metodol&oacute;gico desej&aacute;vel, a verdadeira preval&ecirc;ncia    desta zoonose na capital da rep&uacute;blica. Por outro lado, a demonstra&ccedil;&atilde;o    de que a freq&uuml;&ecirc;ncia de soropositividade para ant&iacute;genos de    <i>T. canis</i> &eacute; sete vezes maior nas crian&ccedil;as que habitam a    periferia de Bras&iacute;lia imp&otilde;e a ado&ccedil;&atilde;o de pol&iacute;tica    p&uacute;blica que privilegie tais popula&ccedil;&otilde;es, protegendo-as,    em car&aacute;ter priorit&aacute;rio, de uma doen&ccedil;a respons&aacute;vel    por sintomas polimorfos e morbidade potencialmente grave.</font></p>     <p>&nbsp;</p>     <p><b><font face="Verdana, Arial, Helvetica, sans-serif" size="3">REFER&Ecirc;NCIAS    BIBLIOGR&Aacute;FICAS</font></b></p>     <!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">1. Ajayi    OO, Duhlinska DD, Agwale SM, Njoku M. Frequency of human toxocariasis in Jos,    Plateau State, Nigeria. Mem&oacute;rias do Instituto Oswaldo Cruz 95: 147-149,    2000.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000066&pid=S0037-8682200300040001300001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">2. Alonso    JM, Bojanich MV, Chamorro M, Gorodner JO. <i>Toxocara</i> seroprevalence in    children from a subtropical city in Argentina. Revista do Instituto de Medicina    Tropical de S&atilde;o Paulo 42: 235-237, 2000.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000067&pid=S0037-8682200300040001300002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">3. Baboolal    S, Rawlins SC. Seroprevalence of toxocariasis in schoolchildren in Trinidad.    Transaction Royal Tropical Medicine and Hygiene 96: 139-143, 2002.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000068&pid=S0037-8682200300040001300003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">4. Beaver    PC, Snyder H. Carrera G. Chronic eosinophilia due to visceral larva migrans:    report of three cases. Pediatrics 9:7-19, 1952.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000069&pid=S0037-8682200300040001300004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">5. Cilla    G, Perez-Trallero E, Gutierrez C, Part C, Gomariz M. Seroprevalence of <i>Toxocara</i>    infection in middle-class and disadvantaged children in northern Spain (Gipuzkoa,    Basque Cauntry). European Journal of Epidemiology 12: 541-543, 1996.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000070&pid=S0037-8682200300040001300005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">6. De Savigny    DH. <i>In vitro</i> maintenance of <i>Toxocara canis</i> larvae and a simple    method for the production of <i>Toxocara</i> ES antigen for use in serodiagnostic    tests for visceral larva migrans. Journal of Parasitology 61: 781-782, 1975.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000071&pid=S0037-8682200300040001300006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">7. De Savigny    DH, Voller A. ELISA for toxocariasis using larval secretory antigens. Transaction    Royal Society of Tropical Medicine and Hygiene 73: 106-115, 1978.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000072&pid=S0037-8682200300040001300007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">8. De Savigny    DH, Voller A, Woodruff AW, Toxocariasis: serological diagnosis by enzyme immunoassay.    Journal of Clinical Pathology 32: 284-288, 1979.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000073&pid=S0037-8682200300040001300008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">9. Elefant    GR, Jacob CMA, Kanashiro EHY, Peres, BA. Toxocar&iacute;ase. <i>In</i>: Ferreira    AW, &Aacute;vila SLM (eds) Diagn&oacute;stico laboratorial das Principais doen&ccedil;as    infecciosas e auto-imunes. 2&ordf; edi&ccedil;&atilde;o Guanabara Koogan. Rio    de Janeiro, p. 323-332, 2001.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000074&pid=S0037-8682200300040001300009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">10. Gueglio    B, de Gentile L, Nguyen JM, Achard J, Chabasse D, Marjolet M. Epidemiological    approach to human toxocariasis in westwern France. Parasitology Research 80:    531-536, 1994.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000075&pid=S0037-8682200300040001300010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">11. Kanamura    HY, Hoshino-Shimizu S, Silva LC. Solubilization of antigen <i>S</i>. <i>mansoni</i>    adult worms for the passive hemagglutination test. Revista do Instituto de Medicina    Tropical de S&atilde;o Paulo 23: 92-95, 1981.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000076&pid=S0037-8682200300040001300011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">12. Lowry    VH, Rosembrouch NJ, Farr AL, Randall RJ. Protein measurement with the folin    phenol reagent. Journal of Biological Chemistry 193: 265-271, 1956.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000077&pid=S0037-8682200300040001300012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">13. Lynch    NR, Hagel I, Vargas V, Rotundo A, Varela MC, Di prisco MC, Hodgen AN. Comparable    seropositivity for ascariasis and toxocariasis in tropical slum children. Parasitololgy    Research 79: 547-550, 1993.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000078&pid=S0037-8682200300040001300013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">14. Nunes    CM, Tundisi RN, Garcia JF, Heinemann MB, Ogassawara S, Richtzenhain LJ. Cross-reaction    between <i>Toxocara canis</i> and <i>Ascaris suum</i> in the diagnosis of visceral    larva migrans by western blotting technique. Revista do Instituto de Medicina    Tropical de S&atilde;o Paulo 39: 1-8, 1997.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000079&pid=S0037-8682200300040001300014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">15. Nunes    CM, Tundisi RN, Heinemann MB, Ogassawara S, Richtzenhain LJ. Toxocariasis: serological    diagnosis by indirect antibody competition ELISA. Revista do Instituto de Medicina    Tropical de S&atilde;o Paulo 41: 95-100, 1999.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000080&pid=S0037-8682200300040001300015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">16. Radman    NE, Archelli SM, Fonrouge RD, del V Guardis M, Linzitto OR. Human toxocariasis.    Its seroprevalence in the city of La Plata. Mem&oacute;rias do Instituto Oswaldo    Cruz 95: 281-285; 2000.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000081&pid=S0037-8682200300040001300016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">17. Shields    JA. Ocular toxocariasis. A review. Survey of Ophtalmolology 28: 361-381, 1984.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000082&pid=S0037-8682200300040001300017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">18. Silva    FM, Le&atilde;o ME, Mendon&ccedil;a HFS, Pereira FEL. Prevalence of anti-<i>Toxocara</i>    antibodies in a random sample of impatients at a children's hospital in Vit&oacute;ria,    Esp&iacute;rito Santo, Brazil. Revista do Instituto de Medicina Tropical de    S&atilde;o Paulo 40: 1-6, 1998.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000083&pid=S0037-8682200300040001300018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">19. Yamasaki    H, Araki K, Chooi Lim PK, Zasmy N, Wah Mak J, Taib R, Aoki T. Development of    a highly specific recombinant <i>Toxocara canis</i> second-stage larva excretory-secretory    antigen for immunodiagnosis of human toxocariasis. Journal of Clinical Microbiology    38: 1409-1413, 2000.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000084&pid=S0037-8682200300040001300019&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p>&nbsp;</p>     <p>&nbsp;</p>     <p><a name="back10"></a><a href="#top"><img src="/img/revistas/rsbmt/v36n4/seta.gif" border="0"></a><b><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Endere&ccedil;o    para correspond&ecirc;ncia    <br>   </font></b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Dr.    Diocl&eacute;cio Campos J&uacute;nior    <br>   SQS 305, Bloco B Apto 305    <br>   70352-020 Bras&iacute;lia, DF    <br>   </font><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Tel:    55 61 242-9063/9966-2658; Fax :55 61 242-3873    <br>   </font><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">e-mail:    <a href="mailto:dicampos@terra.com.br">dicampos@terra.com.br</a></font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Recebido    para publica&ccedil;&atilde;o em 10/9/2002    <br>   </font><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Aceito    em 26/6/2003</font></p>      ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ajayi]]></surname>
<given-names><![CDATA[OO]]></given-names>
</name>
<name>
<surname><![CDATA[Duhlinska]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
<name>
<surname><![CDATA[Agwale]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Njoku]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Frequency of human toxocariasis in Jos, Plateau State, Nigeria]]></article-title>
<source><![CDATA[Memórias do Instituto Oswaldo Cruz]]></source>
<year>2000</year>
<volume>95</volume>
<page-range>147-149</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Bojanich]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
<name>
<surname><![CDATA[Chamorro]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gorodner]]></surname>
<given-names><![CDATA[JO]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Toxocara seroprevalence in children from a subtropical city in Argentina]]></article-title>
<source><![CDATA[Revista do Instituto de Medicina Tropical de São Paulo]]></source>
<year>2000</year>
<volume>42</volume>
<page-range>235-237</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baboolal]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Rawlins]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Seroprevalence of toxocariasis in schoolchildren in Trinidad]]></article-title>
<source><![CDATA[Transaction Royal Tropical Medicine and Hygiene]]></source>
<year>2002</year>
<volume>96</volume>
<page-range>139-143</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Beaver]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Snyder]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Carrera]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Chronic eosinophilia due to visceral larva migrans: report of three cases]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>1952</year>
<volume>9</volume>
<page-range>7-19</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cilla]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Perez-Trallero]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Gutierrez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Part]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gomariz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Seroprevalence of Toxocara infection in middle-class and disadvantaged children in northern Spain (Gipuzkoa, Basque Cauntry)]]></article-title>
<source><![CDATA[European Journal of Epidemiology]]></source>
<year>1996</year>
<volume>12</volume>
<page-range>541-543</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De]]></surname>
<given-names><![CDATA[Savigny DH]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[In vitro maintenance of Toxocara canis larvae and a simple method for the production of Toxocara ES antigen for use in serodiagnostic tests for visceral larva migrans]]></article-title>
<source><![CDATA[Journal of Parasitology]]></source>
<year>1975</year>
<volume>61</volume>
<page-range>781-782</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De]]></surname>
<given-names><![CDATA[Savigny DH]]></given-names>
</name>
<name>
<surname><![CDATA[Voller]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[ELISA for toxocariasis using larval secretory antigens]]></article-title>
<source><![CDATA[Transaction Royal Society of Tropical Medicine and Hygiene]]></source>
<year>1978</year>
<volume>73</volume>
<page-range>106-115</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Savigny]]></surname>
<given-names><![CDATA[DH]]></given-names>
</name>
<name>
<surname><![CDATA[Voller]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Woodruff]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Toxocariasis: serological diagnosis by enzyme immunoassay]]></article-title>
<source><![CDATA[Journal of Clinical Pathology]]></source>
<year>1979</year>
<volume>32</volume>
<page-range>284-288</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Elefant]]></surname>
<given-names><![CDATA[GR]]></given-names>
</name>
<name>
<surname><![CDATA[Jacob]]></surname>
<given-names><![CDATA[CMA]]></given-names>
</name>
<name>
<surname><![CDATA[Kanashiro]]></surname>
<given-names><![CDATA[EHY]]></given-names>
</name>
<name>
<surname><![CDATA[Peres]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Toxocaríase]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
<name>
<surname><![CDATA[Ávila]]></surname>
<given-names><![CDATA[SLM]]></given-names>
</name>
</person-group>
<source><![CDATA[Diagnóstico laboratorial das Principais doenças infecciosas e auto-imunes]]></source>
<year>2001</year>
<edition>2</edition>
<page-range>323-332</page-range><publisher-loc><![CDATA[Rio de Janeiro ]]></publisher-loc>
<publisher-name><![CDATA[Guanabara Koogan]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gueglio]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[de Gentile]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Nguyen]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Achard]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chabasse]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Marjolet]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Epidemiological approach to human toxocariasis in westwern France]]></article-title>
<source><![CDATA[Parasitology Research]]></source>
<year>1994</year>
<volume>80</volume>
<page-range>531-536</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kanamura]]></surname>
<given-names><![CDATA[HY]]></given-names>
</name>
<name>
<surname><![CDATA[Hoshino-Shimizu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Solubilization of antigen S. mansoni adult worms for the passive hemagglutination test]]></article-title>
<source><![CDATA[Revista do Instituto de Medicina Tropical de São Paulo]]></source>
<year>1981</year>
<volume>23</volume>
<page-range>92-95</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lowry]]></surname>
<given-names><![CDATA[VH]]></given-names>
</name>
<name>
<surname><![CDATA[Rosembrouch]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
<name>
<surname><![CDATA[Farr]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Randall]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Protein measurement with the folin phenol reagent]]></article-title>
<source><![CDATA[Journal of Biological Chemistry]]></source>
<year>1956</year>
<volume>193</volume>
<page-range>265-271</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lynch]]></surname>
<given-names><![CDATA[NR]]></given-names>
</name>
<name>
<surname><![CDATA[Hagel]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Rotundo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Varela]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Di]]></surname>
<given-names><![CDATA[prisco MC]]></given-names>
</name>
<name>
<surname><![CDATA[Hodgen]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Comparable seropositivity for ascariasis and toxocariasis in tropical slum children]]></article-title>
<source><![CDATA[Parasitololgy Research]]></source>
<year>1993</year>
<volume>79</volume>
<page-range>547-550</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nunes]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Tundisi]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Heinemann]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Ogassawara]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Richtzenhain]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cross-reaction between Toxocara canis and Ascaris suum in the diagnosis of visceral larva migrans by western blotting technique]]></article-title>
<source><![CDATA[Revista do Instituto de Medicina Tropical de São Paulo]]></source>
<year>1997</year>
<volume>39</volume>
<page-range>1-8</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nunes]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Tundisi]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
<name>
<surname><![CDATA[Heinemann]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Ogassawara]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Richtzenhain]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Toxocariasis: serological diagnosis by indirect antibody competition ELISA]]></article-title>
<source><![CDATA[Revista do Instituto de Medicina Tropical de São Paulo]]></source>
<year>1999</year>
<volume>41</volume>
<page-range>95-100</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Radman]]></surname>
<given-names><![CDATA[NE]]></given-names>
</name>
<name>
<surname><![CDATA[Archelli]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Fonrouge]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[del V Guardis]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Linzitto]]></surname>
<given-names><![CDATA[OR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Human toxocariasis: Its seroprevalence in the city of La Plata]]></article-title>
<source><![CDATA[Memórias do Instituto Oswaldo Cruz]]></source>
<year>2000</year>
<volume>95</volume>
<page-range>281-285</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Ocular toxocariasis]]></article-title>
<source><![CDATA[A review. Survey of Ophtalmolology]]></source>
<year>1984</year>
<volume>28</volume>
<page-range>361-381</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[FM]]></given-names>
</name>
<name>
<surname><![CDATA[Leão]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Mendonça]]></surname>
<given-names><![CDATA[HFS]]></given-names>
</name>
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[FEL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Prevalence of anti-Toxocara antibodies in a random sample of impatients at a children's hospital in Vitória, Espírito Santo, Brazil]]></article-title>
<source><![CDATA[Revista do Instituto de Medicina Tropical de São Paulo]]></source>
<year>1998</year>
<volume>40</volume>
<page-range>1-6</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yamasaki]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Araki]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Chooi]]></surname>
<given-names><![CDATA[Lim PK]]></given-names>
</name>
<name>
<surname><![CDATA[Zasmy]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Wah]]></surname>
<given-names><![CDATA[Mak J]]></given-names>
</name>
<name>
<surname><![CDATA[Taib]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Aoki]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Development of a highly specific recombinant Toxocara canis second-stage larva excretory-secretory antigen for immunodiagnosis of human toxocariasis]]></article-title>
<source><![CDATA[Journal of Clinical Microbiology]]></source>
<year>2000</year>
<volume>38</volume>
<page-range>1409-1413</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
